Fresenius Medical Care Renal Therapies Group product recalled over sterility concerns
- Recall date
- November 13, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Fresenius Medical Care Renal Therapies Group, LLC recalls 0.9% Sodium Chloride Injection, USP, 1000 mL, Rx Only, Fresenius Medical Care North America, Waltham, MA 02451, NDC 492…
- Recall number
- D-0827-2018
- FDA classification
- Class II
- Brand / firm
- Fresenius Medical Care Renal Therapies Group, LLC
- Sold / distributed
- Product was distributed throughout the United States.
Why it was recalled
Lack of Assurance of Sterility
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
0.9% Sodium Chloride Injection, USP, 1000 mL, Rx Only, Fresenius Medical Care North America, Waltham, MA 02451, NDC 49230-0300-10.
Get recall alerts
Free email alert whenever Fresenius Medical Care Renal Therapies Group, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Fresenius Medical Care Renal Therapies Group, LLC